311 related articles for article (PubMed ID: 34496887)
1. Evaluation of intra-ovarian platelet-rich plasma administration on oocytes-dependent variables in patients with poor ovarian response: A retrospective study according to the POSEIDON criteria.
Farimani M; Nazari A; Mohammadi S; Anvari Aliabad R
Reprod Biol Endocrinol; 2021 Sep; 19(1):137. PubMed ID: 34496887
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of intra-ovarian injection of autologous platelet-rich plasma in women with poor responders: a systematic review and meta-analysis.
Vahabi Dastjerdi M; Sheibani S; Taheri M; Hezarcheshmeh FK; Jahangirian J; Jazayeri M; Hosseinirad H; Doohandeh T; Valizadeh R
Arch Gynecol Obstet; 2024 Jun; 309(6):2323-2338. PubMed ID: 38589612
[TBL] [Abstract][Full Text] [Related]
3. The effect of ovarian response parameters and the synergistic effect of assisted reproduction of poor ovarian response treated with platelet rich plasma: systematic review and meta-analysis.
Li W; Xu J; Deng D
BMC Womens Health; 2024 Apr; 24(1):263. PubMed ID: 38678276
[TBL] [Abstract][Full Text] [Related]
4. Relationship Between Anti-Müllerian Hormone and
Sun XY; Lan YZ; Liu S; Long XP; Mao XG; Liu L
Front Endocrinol (Lausanne); 2020; 11():595448. PubMed ID: 33343511
[TBL] [Abstract][Full Text] [Related]
5. Intraovarian platelet-rich plasma injection and IVF outcomes in patients with poor ovarian response: a double-blind randomized controlled trial.
Barrenetxea G; Celis R; Barrenetxea J; Martínez E; De Las Heras M; Gómez O; Aguirre O
Hum Reprod; 2024 Apr; 39(4):760-769. PubMed ID: 38423539
[TBL] [Abstract][Full Text] [Related]
6. Anti-Mullerian hormone as a predictor of ovarian reserve in ART protocols: the hidden role of thyroid autoimmunity.
Magri F; Schena L; Capelli V; Gaiti M; Zerbini F; Brambilla E; Rotondi M; De Amici M; Spinillo A; Nappi RE; Chiovato L
Reprod Biol Endocrinol; 2015 Sep; 13(1):106. PubMed ID: 26391773
[TBL] [Abstract][Full Text] [Related]
7. The ratio of exogenous Luteinizing hormone to Follicle stimulating hormone administered for controlled ovarian stimulation is associated with oocytes' number and competence.
Albu D; Albu A
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31850491
[TBL] [Abstract][Full Text] [Related]
8. Antral follicle count and anti-Müllerian hormone to classify low-prognosis women under the POSEIDON criteria: a classification agreement study of over 9000 patients.
Esteves SC; Yarali H; Vuong LN; Carvalho JF; Özbek İY; Polat M; Le HL; Pham TD; Ho TM
Hum Reprod; 2021 May; 36(6):1530-1541. PubMed ID: 33822057
[TBL] [Abstract][Full Text] [Related]
9. The effect of ovarian injection of autologous platelet rich plasma in patients with poor ovarian responder: a systematic review and meta-analysis.
Li X; Liu H; Lin G; Xu L
Front Endocrinol (Lausanne); 2023; 14():1292168. PubMed ID: 38155954
[TBL] [Abstract][Full Text] [Related]
10. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
Elgindy EA; El-Haieg DO; El-Sebaey A
Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
[TBL] [Abstract][Full Text] [Related]
11. Anti-Müllerian hormone serum values and ovarian reserve: can it predict a decrease in fertility after ovarian stimulation by ART cycles?
Patrelli TS; Gizzo S; Sianesi N; Levati L; Pezzuto A; Ferrari B; Bacchi Modena A
PLoS One; 2012; 7(9):e44571. PubMed ID: 22984527
[TBL] [Abstract][Full Text] [Related]
12. Correlation of serum Anti-Müllerian hormone concentrations on day 3 of the in vitro fertilization stimulation cycle with assisted reproduction outcome in polycystic ovary syndrome patients.
Xi W; Gong F; Lu G
J Assist Reprod Genet; 2012 May; 29(5):397-402. PubMed ID: 22382641
[TBL] [Abstract][Full Text] [Related]
13. Effects of Intraovarian Injection of Autologous Platelet-Rich Plasma on Ovarian Rejuvenation in Poor Responders and Women with Primary Ovarian Insufficiency.
Aflatoonian A; Lotfi M; Saeed L; Tabibnejad N
Reprod Sci; 2021 Jul; 28(7):2050-2059. PubMed ID: 33683669
[TBL] [Abstract][Full Text] [Related]
14. Platelet-rich plasma (PRP) treatment of the ovaries significantly improves fertility parameters and reproductive outcomes in diminished ovarian reserve patients: a systematic review and meta-analysis.
Éliás M; Kónya M; Kekk Z; Turan C; das Virgens IPA; Tóth R; Keszthelyi M; Hegyi P; Várbíró S; Sipos M
J Ovarian Res; 2024 May; 17(1):104. PubMed ID: 38760869
[TBL] [Abstract][Full Text] [Related]
15. Comparison of ART outcome in patients with poor ovarian response according to POSEIDON criteria.
Lee HJ; Noh HK; Joo JK
Sci Rep; 2022 Oct; 12(1):17723. PubMed ID: 36271137
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of anti-Mullerian hormone for pregnancy outcomes following assisted reproductive techniques (ART) in Southwest China.
Liu L; Sun XY; Yang H; Feng XJ; Lan YZ
Reprod Health; 2022 Dec; 19(1):224. PubMed ID: 36514055
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders.
Humaidan P; Chin W; Rogoff D; D'Hooghe T; Longobardi S; Hubbard J; Schertz J;
Hum Reprod; 2017 Mar; 32(3):544-555. PubMed ID: 28137754
[TBL] [Abstract][Full Text] [Related]
18. Do we overlook predictive factors in Poseidon 1 patients? A retrospective analysis co-evaluating antral follicle counts & diameters.
Uncu G; Aslan K; Cakir C; Avci B; Kasapoglu I; Alviggi C
J Ovarian Res; 2024 Jan; 17(1):1. PubMed ID: 38169411
[TBL] [Abstract][Full Text] [Related]
19. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization.
Kunt C; Ozaksit G; Keskin Kurt R; Cakir Gungor AN; Kanat-Pektas M; Kilic S; Dede A
Arch Gynecol Obstet; 2011 Jun; 283(6):1415-21. PubMed ID: 21562964
[TBL] [Abstract][Full Text] [Related]
20. Growth Hormone Cotreatment for Low-Prognosis Patients According to the POSEIDON Criteria.
Liu X; Xu J; Bi L; Liu P; Jiao X
Front Endocrinol (Lausanne); 2021; 12():790160. PubMed ID: 34925245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
